Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Adial Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table1 – Newly Registered Securities

Security Type	Security Class Title		Fee Calculation Rule		Amount Registered(1)(2)			Proposed Maximum Offering Price per Unit(3)		Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee
Equity		Common stock, par value $0.001 per share		Rule 457(c) and Rule 457(h)(2)		120,000	(3)	$	2.1225	$	254,700		$147.60 per $1,000,000	$	37.60
Total Offering Amounts										$	254,700		$147.60 per $1,000,000	$	37.60
Total Fee Offsets(4)															—
Net Fee Due														$	37.60

(1)	The securities to be registered include options and other rights to acquire the common stock, par value $0.001 per share, of Adial Pharmaceuticals, Inc. (the “Registrant”) issuable pursuant to the Registrant’s 2017 Equity Incentive Plan, as amended (the “Plan”).
(2)	Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction.
(3)	Calculated pursuant to Rule 457(c) and 457(h) of the Securities Act solely for purposes of calculating the registration fee. The price for the 120,000 shares of common stock under the Plan is based upon the average of the high and low sale prices of the Registrant’s common stock reported on the Nasdaq Capital Market on December 7, 2023.
(4)	The Registrant does not have any fee offsets to claim.